Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wong, N. D
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review: Cardiovascular risk assessment in the metabolic syndrome, screening for subclinical disease, and implications for treatment

Nathan D Wong

Heart Disease Prevention Program, C240 Medical Sciences, University of California, Irvine, CA 92697, US, ndwong{at}uci.edu

he metabolic syndrome is a clustering of risk factors known to promote or increase the risk for development of cardiovascular disease. Approximately 25—35% of the adult population of developed countries are characterised with metabolic syndrome by different definitions. Metabolic syndrome, even in the absence of diabetes, is associated with an increased risk of cardiovascular disease and total mortality, and is related to an increased risk for the development of diabetes. Initial evaluation of coronary heart disease risk involves global risk estimation using Framingham or other algorithms for risk prediction. Given the absence of key metabolic syndrome risk factors (namely obesity, elevated triglycerides, and impaired fasting glucose) in these algorithms, elevations in these factors need to be considered in individual patient risk evaluation. Further, consideration of screening for novel risk factors such as C-reactive protein, as well as subclinical atherosclerosis (from carotid ultrasound, computed tomography, or ankle-brachial index), can further refine the estimation of future cardiovascular disease risk. The presence of subclinical atherosclerosis or elevated levels of C-reactive protein can potentially modify recommended treatment goals for lipid and other cardiovascular risk factors. The American Heart Association and US National Heart Lung and Blood Institute have recently released revised guidelines for the diagnosis and clinical management of metabolic syndrome. This article examines global assessment of cardiovascular risk in persons with metabolic syndrome, the role of screening for subclinical disease in risk assessment, as well as treatment strategies and their implications for reducing cardiovascular risk in those with metabolic syndrome.

Key Words: metabolic syndrome • epidemiology • prevention • Key words: metabolic syndrome • epidemiology • prevention • coronary heart disease • subclinical atherosclerosis.

References

  • Ford ES, Giles WH, Dietz WH Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.[Abstract/Free Full Text]
  • Third report of the National Cholesterol Education Program (NCEP) expert panel on the detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Circulation 2002;106:3143-421.[Free Full Text]
  • Ford ES Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005;28:2745-9.[Abstract/Free Full Text]
  • Ko GT, Cockram CS, Chow CC et al. High prevalence of metabolic syndrome in Hong Kong Chinese-comparison of three diagnostic criteria. Diab Res Clin Pract 2005;69:160-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tillin T., Forhouhi N., Johnston DG et al. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Dibetologia 2005;48:649-56.[CrossRef]
  • Hu G., Qiao Q., Tuomilehto J. et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004;164:1066-76.[Abstract/Free Full Text]
  • Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart Lung and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.[Free Full Text]
  • Malik S., Wong ND, Franklin SS et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States Adults. Circulation 2004:110:1239-44.
  • Sattar N., Gaw A., Scherbakova O. et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-19.[Abstract/Free Full Text]
  • Isomaa B., Almgren P., Tuomi T. et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.[Abstract/Free Full Text]
  • Ford ES Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-78.[Abstract/Free Full Text]
  • Wong ND, Pio JR, Franklin SS et al. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. Am J Cardiol 2003;91:1421-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hunt KJ, Resendez RG, Williams K., Haffner SM, Stern MP; San Antonio Heart Study. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004; 110:1251-7.[Abstract/Free Full Text]
  • International Diabetes Federation. Worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf. Accessed August 24, 2005.
  • Rutter MK, Meigs JB, Sullivan LM et al. C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study. Circulation 2004;110:380-5.[Abstract/Free Full Text]
  • Malik S., Wong ND, Frankin SS, Pio J., Fairchild C., Chen R. Cardiovascular Disease in US Persons with Metabolic Syndrome, Diabetes, and Elevated C-Reactive Protein. Diabetes Care 2005;28:690-3.[Abstract/Free Full Text]
  • Vu JD, Vu JB, Pio JR et al. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus and pre-existing cardiovascular disease. Am J Cardiol 2005;96:655-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Pearson TA, Mensah GA, Alexander RW et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.[Free Full Text]
  • O'Leary DH, Polak JF, Kronmal RA et al. for the Cardiovascular Health Study Collaborative Research Group: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.[Abstract/Free Full Text]
  • Criqui MH, Langer RD, Fronek A. et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6.[Abstract]
  • Criqui MH, Langer RD, Fronek A., Feigelson HS Coronary disease and stroke in patients with large vessel peripheral arterial disease. Drugs 1991;42(suppl 5):16-21.[CrossRef][Medline] [Order article via Infotrieve]
  • Wong ND, Hsu JC, Detrano RC, Diamond G., Eisenberg H., Gardin JM Coronary artery calcium evaluation by electron beam computed tomography: relation to new cardiovascular events. Am J Cardiol 2000;86:495-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Arad Y., Spadaro LA, Goodman K., Newstein D., Guerci AD Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 2000;36:1253-60.[Abstract/Free Full Text]
  • Kondos GT, Hoff JA, Sevrukov A. et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5,635 initially asymptomatic low to intermediate-risk adults. Circulation 2003; 107:2571-6.[Abstract/Free Full Text]
  • Shaw LJ, Raggi P., Schisterman E., Berman DS, Callister TQ Prognostic value of cardiac risk factors and coronary artery calcium for all-cause mortality. Radiology 2003;228:826-33.[Abstract/Free Full Text]
  • O'Malley PG, Taylor AJ, Jackson JL, Doherty TM, Detrano RC Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asyptomatic populations. Am J Cardiol 2000;85:945-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wilson PWF, Smith SC, Blumenthal RS, Burke GL, Wong ND Task Force #4 - How do we select patients for atherosclerosis imaging? In: 34th Bethesda Conference: can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease. J Am Coll Cardiol 2003;41:1898-906.
  • Wong ND, Sciammarella MG, Polk D. et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 2003;41:1547-53.[Abstract/Free Full Text]
  • Ellison RC, Zhang Y., Wagenknect LE et al. Relation of the metabolic syndrome to calcified atherosclerotic plaque in the coronary arteries and aorta. Am J Cardiol 2005;95:1180-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kullo IJ, Cassidy AE, Peyser PA et al. Association between metabolic syndrome and subclinical coronary atherosclerosis in asymptomatic adults. Am J Cardiol 2004;94:1554-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wong ND, Rozanski AR, Gransar H. et al. Metabolic syndrome increases the likelihood of inducible myocardial ischemia among patients with subclinical atherosclerosis. Diabetes Care 2005;28:1445-50.[Abstract/Free Full Text]
  • Ahluwalia N., Drouet L., Ruidavets JB et al. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis 2005;26(epub)(in press).
  • Burchfiel CM, Skelton TN, Andrew ME Metabolic syndrome and echocardiographic left ventricular mass in blacks: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2005;112:819-27.[Abstract/Free Full Text]
  • McNeill AM, Rosamond WD, Girman CJ et al. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol 2004;94:124 W9-54.
  • Tzou WS, Douglas PS, Srinivasan SR Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol 2005;46:457-63.[Abstract/Free Full Text]
  • Grundy SM, Cleeman JI, Bairey-Merz N. et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004;110:227-39.[Abstract/Free Full Text]
  • Vasan RS, Larson MG, Leip EP et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in The Framingham Heart Study. Lancet 2001;358:1682-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003;289:2560-72.[Abstract/Free Full Text]
  • Pearson TA, Blair SN, Daniels SR et al. American Heart Association guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;106:388-91.[Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 6, 305-313 (2005)
DOI: 10.1177/14746514050050060201
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 British Journal of Diabetes & Vascular DiseaseHome page
A. J Krentz
Effective management of type 2 diabetes and metabolic syndrome: beyond glucose control
The British Journal of Diabetes & Vascular Disease, November 1, 2005; 5(6): 303 - 304.
[PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
S. H Wild and C. D Byrne
Review: Treatment of lipids to reduce cardiovascular risk among people with the metabolic syndrome or type 2 diabetes
The British Journal of Diabetes & Vascular Disease, November 1, 2005; 5(6): 315 - 319.
[Abstract] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wong, N. D
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?